BD biosciences - clontech:1109645 [25-002069]
Ended Awarded Last action
- Contract number
- 75N92B25F00005
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $18,252
Award facts
- Contract value 100% obligated
- $18,252.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Jose, CA 95131, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $18,252 |
About this award
This contract award represents a call under a Blanket Purchase Agreement issued to Becton, Dickinson and Company through its BD Biosciences division for the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health. The contract, valued at $18,252.00 with a firm fixed price structure, was awarded on July 3, 2025, with an ultimate completion date of November 2, 2025. The work will be performed at BD Biosciences' facility in San Jose, California. No small business set-aside was utilized for this procurement. BD Biosciences specializes in providing sophisticated biomedical research instruments, diagnostic equipment, and laboratory consumables, with particular expertise in flow cytometry systems and associated reagents that support federal biomedical research and clinical diagnostics operations.
As a call under an existing BPA vehicle, this award leverages BD Biosciences' established relationship with NIAMS and other NIH components for the provision of laboratory instrumentation, reagents, or related supplies supporting the institute's research mission focused on arthritis, musculoskeletal diseases, and skin disorders. The parent company, Becton, Dickinson and Company, maintains substantial indefinite delivery vehicles and blanket purchase agreements across multiple federal agencies, including numerous NIH institutes and the Department of Veterans Affairs, reflecting its strategic position as a large, qualified supplier of advanced medical technologies essential to federal healthcare delivery and biomedical research operations.
Quick answers
Who was awarded contract 75N92B25F00005?
75N92B25F00005 was awarded to Becton, Dickinson And Company by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on July 3, 2025.
How much is contract 75N92B25F00005 worth?
The government has obligated $18,252 on 75N92B25F00005.
Is contract 75N92B25F00005 an order under another contract?
Yes. 75N92B25F00005 is a BPA call under 75N98024A00047, a blanket purchase agreement.
Was contract 75N92B25F00005 competed?
The extent of competition for 75N92B25F00005 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award